Stock ALDX ALDEYRA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

MarketScreener Editorial Features Aldeyra Therapeutics, Inc.

Equities

ALDX

US01438T1060

Delayed Nasdaq
Other stock markets
 20:57:41 10/05/2024 BST 		5-day change 1st Jan Change
3.77 USD -4.31% Intraday chart for Aldeyra Therapeutics, Inc. -9.25% +7.55%
05-08 Aldeyra Therapeutics Enrolls First Patient in Phase 3 Dry Eye Chamber Study MT
05-08 Aldeyra Therapeutics, Inc. Enrolls First Patient in Phase 3 Clinical Trial Designed to Enable Potential Resubmission of New Drug Application of Reproxalap in Dry Eye Disease CI

MarketScreener Editorial Features

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ALDX Stock
  4. News Aldeyra Therapeutics, Inc.
  5. MarketScreener Editorial Features